Ketonal forte is essentially a regional brand. Its marketing authorisation extends to nine countries clustered across Central and Eastern Europe and the Western Balkans, and its active ingredient is ketoprofen. Travellers familiar with this brand from Poland, Serbia, or Romania are unlikely to encounter the same packaging in Western Europe, North America, or most of Asia, where ketoprofen is sold under different brand names.
Ketoprofen is classified as a non-steroidal anti-inflammatory drug, with analgesic, anti-inflammatory, and antipyretic properties. Ketonal forte is prescribed across a fairly broad range of pain and inflammation indications — including post-surgical pain, neuralgia, and musculoskeletal conditions such as arthritis, osteoarthritis, and rheumatoid arthritis, as well as inflammatory conditions of the mouth and throat such as gingivitis, stomatitis, and laryngitis. The structured indication block further down this page details each registered use in the markets where the product is sold.
The countries where Ketonal forte is registered — among them Bosnia & Herzegovina, the Czech Republic, Georgia, Lithuania, and Slovakia — share overlapping regulatory traditions, which partly explains why the brand has not extended much beyond this regional cluster. A reader who has been prescribed Ketonal forte at home and is now travelling will generally find ketoprofen available in the destination country, often under a different brand name, and the broader NSAID category itself is represented in essentially every regulated pharmacy market worldwide.
A local pharmacist is usually the most practical first point of contact for identifying a regional ketoprofen product or a comparable NSAID. Any decision to begin, continue, or substitute this medication is one to make together with a healthcare provider familiar with the patient's history.